Blood tests study immune and metabolism markers in neurodevelopment
Part of Brain & nervous system, Cancer, Hormones & metabolism, Mental health clinical trials.
This study looks for biological “signals” in blood—related to the immune system and metabolism—to better understand conditions like autism and other brain or development-related disorders. It may help researchers find markers that could guide future diagnosis or treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be diagnosed with autism (ASD) or have another qualifying condition (such as typical development, intellectual disability, epilepsy, brain tumor, or certain psychiatric conditions).
- Ages 0 through 17 years 11 months are eligible.
- You must be willing to have blood drawn for the study.
- You cannot have had a serious bad reaction to a previous blood draw (for example, fainting, severe bruising, or an allergy).
- If the participant is female and able to get pregnant, you must not be pregnant and must not plan pregnancy during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for genetic reasons for autism by collecting blood samples from people with autism, people without autism, and their relatives. The results may help researchers better understand causes and risk factors, even if you only participate through testing a sample.
This study looks at the genetic and molecular profiles of children with autism spectrum disorder (ASD) to better understand the condition and find new treatments. It compares children with ASD who have no known genetic cause to those with a specific genetic syndrome.
This study looks at how people with autism (and some without autism) react during a routine blood test. Researchers will watch and measure behavior and body responses to better understand distress and comfort during needle procedures.
This is an early-stage study exploring a new experimental treatment for autism spectrum disorder (ASD). Researchers will work with your child and family to test whether this approach is safe and how it might help with autism symptoms.
This study follows pregnant parents and their child to understand what factors influence early brain and development. It compares families with an autistic sibling (higher risk) to families without (lower risk) to spot patterns that may help future care.
This study looks at blood samples from children (and sometimes parents) to see if certain protein patterns can help identify or better understand autism spectrum disorder. The results could support finding “biomarkers,” which are measurable signs that may guide future research or care.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.